Cytek Biosciences (CTKB)
(Delayed Data from NSDQ)
$9.35 USD
+0.20 (2.19%)
Updated Mar 21, 2023 04:00 PM ET
After-Market: $9.33 -0.02 (-0.21%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2023
Time: -- |
3/2023 | $0.03 | 0.00% |
Earnings Summary
For their last quarter, Cytek Biosciences (CTKB) reported earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This reflects a positive earnings surprise of 40.00%. Look out for CTKB's next earnings release expected on May 10, 2023. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year increase of 200%.
Earnings History
Price & Consensus
Zacks News for CTKB
Cytek Biosciences, Inc. (CTKB) Q3 Earnings Surpass Estimates
CTKB: What are Zacks experts saying now?
Zacks Private Portfolio Services